ArticleCardiology and therapy2019

Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies.

Heidi T May et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.